CFTR2: How will it help care?

Area of Science:

• Genetics
• Molecular Biology
• Medical Research

Background:

• Cystic Fibrosis (CF) is a genetic disorder caused by mutations in the CFTR gene.
• Accurate annotation of CFTR mutations is crucial for understanding disease mechanisms and patient management.
• The Clinical and Functional Translation of CFTR (CFTR2) project addresses the need for comprehensive mutation data.

Purpose of the Study:

• To develop a novel approach for clinical and functional annotation of CFTR mutations.
• To evaluate the disease liability of the 160 most frequently reported CFTR mutations.
• To create a publicly accessible resource for CFTR mutation information.

Main Methods:

• Collected phenotype and genotype data from approximately 40,000 cystic fibrosis patients.
• Employed a multistage evaluation process including clinical (sweat chloride), functional (cell-based expression), and epidemiological (obligate heterozygote analysis) steps.
• Analyzed the disease liability of 160 common CFTR mutations.

Main Results:

• Generated a comprehensive dataset on CFTR mutation clinical and functional characteristics.
• Detailed evaluation of the disease liability for frequently reported CFTR mutations.
• Results are accessible via a dedicated website.

Conclusions:

• The CFTR2 project provides valuable data for various aspects of cystic fibrosis care.
• Data can inform diagnosis, newborn screening, carrier testing, and genotype/phenotype correlations.
• Findings support the development of mutation-specific therapeutics for cystic fibrosis.